Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:51:25 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:ANGO - ANGIODYNAMICS INC - http://www.angiodynamics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ANGO - Q0.15.03·7.365.05.81+0.030.5313.31,6851,8985.78  6.44  5.7611.38  5.2616:20:00Apr 0415 min RT 2¢

Recent Trades - Last 10 of 1898
Time ETExPriceChangeVolume
16:20:00Q5.810.03302
16:13:42Q5.810.0314
16:01:38Q5.810.03913
16:00:11Q5.810.03117
16:00:11Q5.810.03101
16:00:04Q5.810.03302
16:00:01Q5.810.0368
16:00:01Q5.810.032
16:00:01Q5.810.03500
16:00:01Q5.810.03834

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-04 07:00U:ANGONews ReleaseAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
2024-04-04 06:45U:ANGONews ReleaseAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
2024-04-01 17:26U:ANGONews ReleaseAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
2024-03-19 16:01U:ANGONews ReleaseAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
2024-03-06 16:01U:ANGONews ReleaseAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
2024-02-15 16:05U:ANGONews ReleaseAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
2024-01-23 08:00U:ANGONews ReleaseAngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
2024-01-05 07:00U:ANGONews ReleaseAngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
2023-12-21 16:01U:ANGONews ReleaseAngioDynamics to Present at the J.P. Morgan Healthcare Conference
2023-12-07 16:01U:ANGONews ReleaseAngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
2023-12-07 08:00U:ANGONews ReleaseAngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
2023-10-04 07:00U:ANGONews ReleaseAngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
2023-09-12 16:01U:ANGONews ReleaseAngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
2023-08-15 16:01U:ANGONews ReleaseAngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
2023-08-03 08:00U:ANGONews ReleaseAngioDynamics Completes Enrollment for PRESERVE Clinical Study
2023-07-31 16:01U:ANGONews ReleaseAngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
2023-07-24 16:01U:ANGONews ReleaseAngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
2023-07-12 07:00U:ANGONews ReleaseAngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
2023-06-20 16:01U:ANGONews ReleaseAngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
2023-06-08 16:01U:ANGONews ReleaseAngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million